The Amelioration of Insulin Resistance in Salt Loading Subjects by Potassium Supplementation is Associated with a Reduction in Plasma IL-17A Levels

Abstract

Background High dietary salt intake contributes to the development of autoimmune/inflammatory diseases including metabolic syndrome (MetS) which potassium supplementation can potentially reverse. T helper (Th) 17 cells as well as its production interleukin (IL)-17A are involved in the pathogenesis of MetS. The polarization of Th17 cells and enhanced IL-17A production induced by high salt might increase the risk of autoimmune/inflammatory diseases.

Methods 45 normotensive subjects (aged 29 to 65 years) were enrolled from a rural community of Northern China at random. All of the participants were maintained on a low-salt (3 g/day) diet for 7 days, a high-salt (18 g/day) diet for 7 days, and then a high-salt diet with potassium supplementation (4.5 g/day, KCl) for another 7 days. Insulin resistance (IR) was determined based on the homeostasis model assessment index (HOMA-IR).

Results Participants exhibited increased plasma insulin level, as well as progressed HOMA-IR, during a high-salt diet intervention, which potassium supplementation reversed. Moreover, after salt loading, the plasma IL-17A concentrations increased significantly (4.2±2.1 pg/mL to 9.7±5.1 pg/mL; P<0.01), whereas dropped considerably when dietary potassium was supplemented (9.7±5.1 pg/mL to 2.0±0.9 pg/mL; P<0.001). Statistically significant correlations were found between changes in HOMA-IR and changes in plasma IL-17A concentrations during the interventions (low- to high-salt: r=0.642, P<0.01; high-salt to potassium supplementation: r=0.703, P<0.01). Based on multivariate regression analysis, plasma IL-17A showed as an independent predictor of IR.

Conclusions The amelioration of salt-loading-induced IR by potassium supplementation in participants may be related to the reduction in plasma IL-17A concentration.

Key words

insulin resistance - Th17 - IL-17A - high salt consumption - potassium supplementation

• References

• 1 Elliott P, Stamler J, Nichols R. et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ 1996; 312: 1249-1253
• 2 Gu D, Zhao Q, Chen J. et al. Reproducibility of blood pressure responses to dietary sodium and potassium interventions: the GenSalt study. Hypertension 2013; 62: 499-505
• 3 Adrogue HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 2007; 356: 1966-1978
• 4 Tobian L. Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension 1991; 17: I52-158
• 5 Mei H, Rice TK, Gu D. et al. Genetic correlation of blood pressure responses to dietary sodium and potassium intervention and cold pressor test in Chinese population. J Hum Hypertens 2011; 25: 500-508
• 6 Morimoto A, Uzu T, Fujii T. et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 1997; 350: 1734-1737
• 7 Fang Y, Mu JJ, He LC. et al. Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supplement in normotensive salt-sensitive asians. Hypertension 2006; 48: 724-729
• 8 D’Elia L, Barba G, Cappuccio FP. et al. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies. J Am Coll Cardiol 2011; 57: 1210-1219
• 9 Aburto NJ, Hanson S, Gutierrez H. et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ 2013; 346: f1378
• 10 Whelton PK, He J, Cutler JA. et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997; 277: 1624-1632
• 11 Baudrand R, Campino C, Carvajal CA. et al. High sodium intake is associated with increased glucocorticoid production, insulin resistance and metabolic syndrome. Clin Endocrinol (Oxf) 2014; 80: 677-684
• 12 Vedovato M, Lepore G, Coracina A. et al. Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance. Diabetologia 2004; 47: 300-303
• 13 Chen J, Gu D, Huang J. et al. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet 2009; 373: 829-835
• 14 Ekinci EI, Cheong KY, Dobson M. et al. High sodium and low potassium intake in patients with Type 2 diabetes. Diabet Med 2010; 27: 1401-1408
• 15 Shin D, Joh HK, Kim KH. et al. Benefits of potassium intake on metabolic syndrome: The fourth Korean National Health and Nutrition Examination Survey (KNHANES IV). Atherosclerosis 2013; 230: 80-85
• 16 Chatterjee R, Colangelo LA, Yeh HC. et al. Potassium intake and risk of incident type 2 diabetes mellitus: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetologia 2012; 55: 1295-1303
• 17 Teramoto T, Kawamori R, Miyazaki S. et al. Sodium intake in men and potassium intake in women determine the prevalence of metabolic syndrome in Japanese hypertensive patients: OMEGA Study. Hypertens Res 2011; 34: 957-962
• 18 Lee H, Lee J, Hwang SS. et al. Potassium intake and the prevalence of metabolic syndrome: the Korean National Health and Nutrition Examination Survey 2008–2010. PLoS One 2013; 8: e55106
• 19 Ogihara T, Asano T, Ando K. et al. High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 2002; 40: 83-89
• 20 Ogihara T, Asano T, Ando K. et al. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats. Diabetes 2001; 50: 573-583
• 21 Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27: 813-823
• 22 Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801
• 23 Greenfield JR, Campbell LV. Relationship between inflammation, insulin resistance and type 2 diabetes: ‘cause or effect’?. Curr Diabetes Rev 2006; 2: 195-211
• 24 Sjoholm A, Nystrom T. Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev 2006; 22: 4-10
• 25 Gaffen SL. Recent advances in the IL-17 cytokine family. Curr Opin Immunol 2011; 23: 613-619
• 26 Cheng X, Yu X, Ding YJ. et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008; 127: 89-97
• 27 Shao S, He F, Yang Y. et al. Th17 cells in type 1 diabetes. Cell Immunol 2012; 280: 16-21
• 28 Jagannathan-Bogdan M, McDonnell ME, Shin H. et al. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol 2011; 186: 1162-1172
• 29 Zeng C, Shi X, Zhang B. et al. The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med (Berl) 2012; 90: 175-186
• 30 Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8: 345-350
• 31 Kleinewietfeld M, Manzel A, Titze J. et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013; 496: 518-522
• 32 Wu C, Yosef N, Thalhamer T. et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013; 496: 513-517
• 33 Garg R, Williams GH, Hurwitz S. et al. Low-salt diet increases insulin resistance in healthy subjects. Metabolism 2011; 60: 965-968
• 34 Garg R, Sun B, Williams J. Effect of low salt diet on insulin resistance in salt-sensitive versus salt-resistant hypertension. Hypertension 2014; 64: 1384-1387
• 35 Reungjui S, Roncal CA, Mu W. et al. Thiazide diuretics exacerbate fructose-induced metabolic syndrome. J Am Soc Nephrol 2007; 18: 2724-2731
• 36 Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 2010; 159: 109-119
• 37 Harrington LE, Hatton RD, Mangan PR. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132
• 38 Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8: 337-348
• 39 Zhou L, Ivanov II, Spolski R. et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8: 967-974
• 40 Korn T, Bettelli E, Oukka M. et al. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27: 485-517
• 41 Fabbrini E, Cella M, McCartney SA. et al. Association between specific adipose tissue CD4+T-cell populations and insulin resistance in obese individuals. Gastroenterology 2013; 145 (366/74) e1-e3
• 42 Chuang HC, Sheu WH, Lin YT. et al. HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance. Nat Commun 2014; 5: 4602